Picture of IR BioSciences Holdings logo

IRBS IR BioSciences Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for IR BioSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2006
December 31st
2007
December 31st
2008
December 31st
2009
December 31st
2010
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSB10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.49-5.46-5.81-6.46-5.28
Depreciation
Non-Cash Items-0.5242.490.9763.52.96
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0340.5030.0440.0761.88
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-2.04-2.46-4.77-2.88-0.43
Capital Expenditures-0.032-0.025-0.02-0.0020
Purchase of Fixed Assets
Cash from Investing Activities-0.032-0.025-0.02-0.0020
Financing Cash Flow Items00000
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.55-0.057.7300.15
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.49-2.532.94-2.88-0.28